Merck
CN

Sclerotherapy with polidocanol for treatment of aneurysmal bone cysts.

Acta orthopaedica (2013-11-01)
Otte Brosjö, Pierre Pechon, Asle Hesla, Panagiotis Tsagozis, Henrik Bauer
ABSTRACT

Recent data suggest that percutaneous sclerotherapy is a safe alternative to surgery for treatment of aneurysmal bone cysts (ABCs). We present our experience of this method. We retrospectively analyzed data from 38 consecutive patients treated with repeated injections of polidocanol. Each injection consisted of 2-4 mg polidocanol per kg body weight. Radiological and clinical assessments were performed until healing. All cycts except 1 healed after a median of 4 (1-11) injections. A lesion failed to heal in 1 patient, who was operated. 3 patients experienced minor local inflammatory reactions. Our results show that percutaneus sclerotherapy with polidocanol has high efficacy in the treatment of ABCs, with a low frequency of side effects. Our findings corroborate data presented in previous publications. We believe that the method will be especially valuable in ABCs of the pelvis and sacrum, where surgery is associated with considerable morbidity.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
ECO BRIJ® L4, average Mn ~362
Sigma-Aldrich
ECO Brij® L23
Sigma-Aldrich
Decaethylene glycol mono­dodecyl ether, nonionic surfactant
Sigma-Aldrich
Thesit®, for membrane research
Sigma-Aldrich
Brij® L23 solution, 30 % (w/v) in H2O
Sigma-Aldrich
Brij® L23, suitable for Stein-Moore chromatography
Sigma-Aldrich
Brij® L23, main component: tricosaethylene glycol dodecyl ether
Sigma-Aldrich
Brij® L4, average Mn ~362